Entresto: a new heart failure drug
Pharmacy Magazine,
1 Min
Clinical
Entresto: a new heart failure drug
Pharmacy Magazine,
1 Min
In Clinical
Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.
Bookmark
Record learning outcomes
Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure with reduced ejection fraction. Novartis says that sacubitril plus valsartan reduces the risk of cardiovascular death and first hospitalisation for heart failure by 20 per cent when compared to enalapril, equivalent to an absolute risk reduction of 4.7 per cent.
Copy Link
Record my learning outcomes
Save for later
Clinical
Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.
In Clinical
Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.